Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection

dc.contributor.authorDrennan, Michael B.
dc.contributor.authorNicolle, Delphine
dc.contributor.authorQuesniaux, Valerie J. F.
dc.contributor.authorJacobs, Muazzam
dc.contributor.authorAllie, Nasiema
dc.contributor.authorMpagi, Joseph L.
dc.contributor.authorFremond, Cecile
dc.contributor.authorWagner, Hermann
dc.contributor.authorKirschning, Carsten
dc.contributor.authorRyffe, Bernhard
dc.date.accessioned2019-02-14T13:42:01Z
dc.date.available2019-02-14T13:42:01Z
dc.date.issued2004
dc.description.abstractRecognition of Mycobacterium tuberculosis by the innate immune system is essential in the development of an adaptive immune response. Mycobacterial cell wall components activate macrophages through Toll-like receptor (TLR) 2, suggesting that this innate immune receptor plays a role in the host response to M. tuberculosis infection. After aerosol infection with either 100 or 500 live mycobacteria, TLR2-deficient mice display reduced bacterial clearance, a defective granulomatous response, and develop chronic pneumonia. Analysis of pulmonary immune responses in TLR2-deficient mice after 500 mycobacterial aerosol challenge showed increased levels of interferon- , tumor necrosis factor- , and interleukin-12p40 as well as increased numbers of CD4 and CD8 cells. Furthermore, TLR2-deficient mice mounted elevated Ag-specific type 1 T-cell responses that were not protective because all deficient mice succumb to infection within 5 months. Taken together, the data suggests that TLR2 may function as a regulator of inflammation, and in its absence an exaggerated immune inflammatory response developsen_US
dc.identifier.issn1525-2191
dc.identifier.urihttp://hdl.handle.net/20.500.12283/227
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectInfectionen_US
dc.subjectReceptor 2en_US
dc.subjectDeficienten_US
dc.subjectMiceen_US
dc.titleToll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infectionen_US
dc.typeArticleen_US

Drennan_Tol_BUFHS_2004.pdf
929.41 KB
Adobe Portable Document Format
Journal Article

license.txt
1.71 KB
Item-specific license agreed upon to submission